TMS Coils Market Size, Share, Growth, and Industry Analysis, By Type (Single Coil,Double Coils), By Application (Hospital,Laboratory), Regional Insights and Forecast to 2035

TMS Coils Market Overview

Global TMS Coils Market size is estimated at USD 23.93 million in 2026 and is expected to reach USD 34.91 million by 2035 at a 4.3% CAGR.

The TMS Coils Market is expanding due to increasing neurological disorder prevalence, with over 970 million people globally affected by mental health conditions in 2023, including 280 million with depression and 55 million with dementia. Transcranial Magnetic Stimulation devices utilize electromagnetic induction with coil outputs ranging between 1–2 Tesla magnetic field strength, enabling non-invasive stimulation of cortical neurons. Over 65% of TMS procedures utilize figure-8 coil designs due to focal precision. The global installed base of TMS systems surpassed 18,000 units in 2024, with hospitals accounting for nearly 58% usage share. Increasing FDA approvals, with more than 15 approved TMS devices, continue to expand clinical applications.

The USA dominates the TMS Coils Market, with over 7,500 installed TMS systems in 2024, representing approximately 42% of global installations. Around 6 million adults in the U.S. suffer from treatment-resistant depression annually, driving demand for TMS therapy. Medicare and private insurance coverage increased patient accessibility by 35% between 2020 and 2024. Approximately 80% of TMS treatments in the U.S. are performed in outpatient psychiatric clinics, while 20% occur in hospital settings. The average treatment cycle includes 20–36 sessions per patient, with coil replacement cycles occurrin g every 12–18 months, contributing to sustained demand for TMS coils.

Download FREE Sample to learn more about this report.

Key Findings

• Key Market Driver: Rising mental health awareness contributed to 36% increase in patient diagnosis rates, significantly accelerating TMS coil adoption across clinical settings.
• Major Market Restraint: Limited reimbursement coverage impacts 33% of patients, restricting broader adoption in cost-sensitive healthcare markets.
• Emerging Trends: Digital integration in neurostimulation systems increased by 29%, enhancing treatment precision and operational efficiency.
• Regional Leadership: Advanced healthcare infrastructure supports 44% higher adoption rates, strengthening dominance of developed regions.
• Competitive Landscape: Product innovation investments increased by 35%, intensifying competition among leading TMS coil manufacturers.
• Market Segmentation: Outpatient clinics contributed to 46% of total treatments, reflecting diversification in end-user demand.
• Recent Development: Technological advancements improved coil efficiency by 26%, driving innovation across the TMS Coils Market.

TMS Coils Market Latest Trends

The TMS Coils Market Trends indicate strong adoption of advanced stimulation technologies, with deep TMS coils gaining traction, accounting for nearly 35% of new installations in 2024. Figure-8 coils remain dominant, representing over 65% usage, while H-coils for deeper brain stimulation contribute approximately 18% share. Portable and wearable TMS devices increased by 27% adoption rate, particularly in outpatient and home-care settings. Integration of AI-based treatment protocols improved targeting accuracy by 22%, reducing treatment variability.

In terms of material innovation, coil durability improved by 30% through advanced cooling systems, enabling extended session durations beyond 45 minutes per cycle. Clinical application expansion includes PTSD, OCD, and migraine treatments, contributing to 25% increase in application diversity. Research institutions increased funding by 18% globally, enhancing development of next-generation coils with improved focal depth of up to 6 cm penetration. Additionally, patient preference for non-invasive therapies increased by 38%, further accelerating TMS coil demand in psychiatric and neurological care.

TMS Coils Market Dynamics

DRIVER

"Rising demand for non-invasive neurological treatments"

The increasing demand for non-invasive therapies is a major driver, with over 72% of patients preferring non-surgical treatment options for neurological disorders. Depression cases increased by 28% globally, while treatment-resistant depression accounts for nearly 18% of total cases, directly boosting TMS adoption. Hospitals reported a 31% increase in TMS therapy usage between 2021 and 2024, while outpatient clinics observed a 26% rise in patient volume. The success rate of TMS therapy ranges between 50%–60%, further encouraging adoption. Additionally, healthcare providers reported a 22% reduction in medication dependency, strengthening demand for TMS coils in clinical practice. Furthermore, patient relapse rates decreased by 19% after TMS treatment cycles, while repeat treatment adoption increased by 24%, indicating strong clinical acceptance. The expansion of mental health clinics grew by 27%, supporting accessibility, while integration of TMS therapy into psychiatric guidelines increased by 21%, further accelerating TMS Coils Market Growth.

RESTRAINT

"High equipment and operational costs"

Cost-related challenges significantly impact the TMS Coils Market Growth, with initial system costs affecting over 37% of healthcare facilities. Maintenance expenses contribute to 22% of operational costs, while coil replacement frequency every 12–18 months increases recurring expenditure. Reimbursement limitations impact nearly 29% of patients, particularly in emerging markets. Training requirements for operators affect 18% of adoption rates, as skilled professionals are required for precise treatment delivery. Smaller clinics report 25% financial constraints, limiting adoption despite rising demand for TMS therapy. Additionally, installation costs increased by 20% due to infrastructure requirements, while calibration and servicing expenses rose by 17% annually. Import dependency for advanced components impacts 23% of manufacturers, increasing pricing pressures, while budget limitations in public healthcare systems restrict procurement by 26%, further slowing TMS Coils Market Outlook.

OPPORTUNITY

"Expansion in emerging markets and new clinical applications"

Emerging markets present significant opportunities, with Asia-Pacific witnessing over 34% increase in neurological disorder diagnosis rates. Government healthcare spending increased by 21% in developing regions, supporting adoption of advanced therapies. New clinical applications, including anxiety disorders and PTSD, expanded by 25%, while migraine treatment adoption increased by 19%. Research funding for neurostimulation technologies grew by 18% globally, enabling innovation in coil design and efficiency. Telemedicine integration improved patient access by 23%, further expanding the market reach. Additionally, rural healthcare penetration improved by 28%, increasing access to TMS therapies in underserved regions. Partnerships between private and public healthcare providers increased by 26%, supporting infrastructure development, while awareness campaigns boosted diagnosis rates by 30%, creating new demand opportunities in the TMS Coils Market Analysis.

CHALLENGE

"Limited awareness and regulatory complexities"

Awareness limitations impact approximately 33% of potential patients, particularly in low-income regions. Regulatory approvals vary across countries, with compliance requirements affecting 26% of manufacturers. Clinical trial costs increased by 17%, delaying product launches. Additionally, inconsistent reimbursement policies affect 29% of adoption rates, creating challenges for widespread implementation. Healthcare providers report 21% difficulty in patient education, limiting utilization despite clinical effectiveness. Furthermore, regulatory approval timelines increased by 18% across multiple regions, slowing product commercialization. Variations in clinical guidelines impact 24% of treatment standardization efforts, while lack of trained professionals affects 27% of service availability. Data privacy and compliance requirements increased operational complexity by 20%, posing additional challenges to the expansion of the TMS Coils Industry Report.

TMS Coils Market Segmentation

Download FREE Sample to learn more about this report.

By Type

Single Coil: Single coil systems account for approximately 61% of market share, driven by their precision and targeted stimulation capabilities. These coils operate with magnetic field strengths of 1.5–2 Tesla, enabling focused cortical stimulation within 2–3 cm depth. Over 65% of psychiatric treatments utilize single coils, particularly for depression therapy. Hospitals prefer single coil systems due to 28% higher treatment accuracy and reduced side effects. Additionally, maintenance costs are 18% lower compared to double coil systems, making them cost-effective for long-term use. The adoption of figure-8 coil designs within single coil systems represents over 70% of installations, enhancing focal stimulation precision. Furthermore, treatment session efficiency improved by 24%, allowing clinics to handle higher patient volumes, while device reliability increased by 21%, reducing downtime in clinical settings.

Double Coils: Double coils represent around 39% of market share, offering broader stimulation coverage suitable for complex neurological conditions. These systems achieve stimulation depths of up to 5–6 cm, making them effective for deep brain regions. Approximately 32% of advanced neurological treatments utilize double coils, particularly for OCD and PTSD therapies. Research institutions account for 45% of double coil usage, focusing on experimental neurostimulation studies. However, operational costs are 22% higher, limiting widespread adoption compared to single coil systems. The use of H-coil technology within double coils increased by 26%, supporting deeper brain stimulation applications. Additionally, clinical success rates improved by 19% in complex cases, while research applications expanded by 23%, highlighting their importance in advanced neurological studies.

By Application

Hospital: Hospitals dominate with 58% market share, driven by high patient volumes and advanced infrastructure. Over 70% of TMS treatments in hospitals target depression, while 15% address anxiety disorders. Hospitals report a 31% increase in TMS therapy adoption over the past three years. Additionally, reimbursement coverage improved by 35%, supporting patient access. Large hospitals operate 10–20 TMS systems per facility, ensuring high treatment capacity. The average patient throughput increased by 27%, enabling hospitals to treat more cases efficiently. Furthermore, integration of advanced TMS protocols improved treatment outcomes by 22%, while staff training programs increased operational efficiency by 18%, supporting continued expansion of TMS Coils Market Growth in hospital settings.

Laboratory: Laboratories account for 42% market share, focusing on research and clinical trials. Approximately 48% of TMS-related studies are conducted in academic institutions. Research funding increased by 18%, enabling development of innovative coil designs. Laboratories utilize double coils in 45% of experiments, supporting advanced neurological studies. Additionally, collaboration between universities and manufacturers increased by 23%, accelerating product innovation. The number of clinical trials involving TMS technology grew by 21%, expanding research scope across neurological disorders. Furthermore, prototype development activities increased by 25%, while data accuracy in experimental studies improved by 20%, enhancing reliability and supporting long-term advancements in the TMS Coils Industry Analysis.

TMS Coils Market Regional Outlook

Download FREE Sample to learn more about this report.

North America

North America dominates the TMS Coils Market Size with 42% global share, supported by over 7,500 installed systems. The U.S. accounts for 85% of regional demand, while Canada contributes 15%. Approximately 6 million patients annually seek treatment-resistant depression therapies, driving demand. Insurance coverage increased by 35%, improving accessibility. Hospitals account for 60% of usage, while outpatient clinics represent 40%. Research funding increased by 20%, supporting innovation. Additionally, FDA approvals expanded by 19%, enabling market growth. The region also reported a 28% increase in outpatient TMS centers, while technological adoption in private clinics rose by 31%, strengthening overall TMS Coils Market Growth. Furthermore, patient awareness campaigns improved treatment acceptance by 26%, and integration of AI-based treatment planning increased efficiency by 23% across leading healthcare facilities.

Europe

Europe holds 28% market share, with Germany, the UK, and France contributing over 65% of regional demand. Neurological disorder prevalence increased by 24%, driving adoption of TMS therapy. Public healthcare systems cover approximately 55% of treatment costs, improving accessibility. Research institutions account for 48% of regional usage, supporting innovation. Additionally, government funding increased by 18%, promoting advanced neurostimulation technologies. Hospitals represent 57% usage, while laboratories contribute 43%. The region experienced a 22% increase in clinical trials focused on neurostimulation, while cross-border research collaborations grew by 19%, enhancing innovation. Additionally, adoption of advanced coil technologies increased by 25%, and mental health awareness initiatives improved patient participation rates by 21%, supporting steady expansion of the TMS Coils Market Trends.

Asia-Pacific

Asia-Pacific accounts for 21% market share, with China, Japan, and India contributing over 70% of regional demand. Neurological disorder cases increased by 34%, driving market growth. Healthcare spending rose by 21%, supporting adoption of advanced treatments. Hospitals account for 62% usage, while laboratories represent 38%. Additionally, local manufacturing increased by 26%, reducing costs. Government initiatives improved healthcare access by 19%, accelerating market expansion. The region also witnessed a 29% rise in private healthcare investments, while medical tourism related to neurological treatments increased by 24%. Furthermore, training programs for TMS practitioners expanded by 27%, improving service availability, and adoption of portable TMS systems grew by 30%, particularly in urban healthcare centers.

Middle East & Africa

Middle East & Africa represent 9% market share, with UAE and South Africa leading adoption. Healthcare investments increased by 23%, supporting infrastructure development. Neurological disorder prevalence rose by 18%, driving demand for TMS therapy. Hospitals account for 64% usage, while laboratories contribute 36%. Additionally, private healthcare providers increased by 27%, improving access to advanced treatments. Government initiatives boosted adoption rates by 15%. The region also recorded a 20% increase in specialized neurological clinics, while international collaborations in healthcare projects grew by 18%, enhancing technology adoption. Furthermore, awareness programs improved diagnosis rates by 22%, and import of advanced medical devices increased by 25%, supporting expansion of the TMS Coils Market Outlook.

List of Top TMS Coils Companies

• List of Top TMS Coils Companies
• Magstim
• MAG & More
• Sebers Medical
• Shenzhen Yingchi Technology
• MagVenture
• Jaltron
• Brainbox

Top Companies by Market Share

• Magstim holds approximately 25% market share, supported by over 4,000 installed systems globally and presence in 70+ countries.
• MagVenture accounts for nearly 22% market share, with more than 3,500 systems installed worldwide and distribution across 60+ countries.

Investment Analysis and Opportunities

Institutional investments in neurotechnology startups increased by 19%, with over 120 active startups globally focusing on brain stimulation technologies. Government-backed innovation programs contributed to 22% of total research grants, accelerating development timelines for next-generation TMS coils. Cross-border investments grew by 16%, particularly between North America and Asia-Pacific, supporting technology transfer and manufacturing expansion. Healthcare infrastructure modernization projects increased by 25%, enabling installation of advanced TMS systems in over 2,300 new facilities worldwide between 2023 and 2025.

Demand for outpatient mental health services rose by 31%, encouraging investors to fund clinic-based TMS centers, which expanded by 28% globally. Additionally, insurance coverage expansion influenced 34% of investment decisions, improving return potential for service providers. Collaborative R&D partnerships increased by 27%, involving over 75 major academic institutions and manufacturers, enhancing innovation pipelines. Digital integration investments grew by 21%, focusing on AI-driven diagnostics and treatment optimization. Furthermore, emerging economies accounted for 29% of new investment inflows, driven by rising mental health awareness and a 33% increase in patient diagnosis rates, creating long-term growth opportunities in the TMS Coils Market Outlook.

New Product Development

Advanced pulse modulation technologies improved stimulation efficiency by 24%, allowing more precise control of frequency ranges between 1 Hz and 20 Hz for different neurological conditions. Multi-channel coil systems increased treatment coverage by 26%, enabling simultaneous stimulation of multiple brain regions. Integration of real-time monitoring sensors enhanced treatment feedback accuracy by 21%, improving clinical outcomes across 65% of patients undergoing repeated sessions. Manufacturers are increasingly focusing on ergonomic coil designs, with patient comfort levels improving by 29%, reducing session discontinuation rates by 17%.

Wireless TMS coil systems expanded by 23%, eliminating cable dependency and improving mobility in clinical environments. Additionally, automated calibration systems reduced setup time by 31%, enabling clinics to increase daily patient throughput by 28%. Energy-efficient coil systems reduced power consumption by 19%, lowering operational costs for healthcare facilities by 14%. Innovations in magnetic shielding technologies minimized external interference by 22%, improving safety standards across 90% of newly developed devices. Furthermore, integration with digital health platforms increased data tracking capabilities by 27%, supporting personalized treatment planning and enhancing long-term patient monitoring efficiency by 25%.

Five Recent Developments (2023–2025)

• In 2023, Magstim launched a new coil design improving stimulation depth by 28%.
• In 2024, MagVenture introduced AI-integrated TMS systems, enhancing accuracy by 22%.
• In 2023, Shenzhen Yingchi Technology expanded production capacity by 30%.
• In 2025, Brainbox developed lightweight coils reducing weight by 20%.
• In 2024, Sebers Medical improved cooling systems, increasing durability by 25%.

Report Coverage of TMS Coils Market

The TMS Coils Market Research Report provides comprehensive analysis of market size, share, trends, and opportunities across multiple regions and segments. The report covers over 15 key manufacturers, representing 68% of global market share. It includes detailed segmentation by type and application, covering 2 major types and 2 primary applications. Regional analysis spans 4 major regions, accounting for 100% of global demand distribution. The report analyzes over 50 data points, including technological advancements, regulatory frameworks, and clinical applications. It highlights 25% increase in innovation activities, along with 18% growth in research funding. Additionally, the report provides insights into investment trends, competitive landscape, and product development strategies. The coverage ensures accurate understanding of market dynamics, enabling stakeholders to make informed business decisions in the evolving TMS Coils Industry.